{"transactions":[{"id":2385309,"issuer":{"id":130187,"kind":"organization","name":"CASTLIGHT HEALTH, INC.","symbol":"CSLT"},"owners":[{"id":130197,"kind":"organization","name":"VENROCK ASSOCIATES V LP","position":1,"cik":"0001391289","reported_name":"VENROCK ASSOCIATES V LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130198,"kind":"organization","name":"VENROCK PARTNERS V L P","position":2,"cik":"0001395760","reported_name":"VENROCK PARTNERS V L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130199,"kind":"organization","name":"Venrock Entrepreneurs Fund V, L.P.","position":3,"cik":"0001444114","reported_name":"Venrock Entrepreneurs Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106037,"kind":"organization","name":"Venrock Management V, LLC","position":4,"cik":"0001444116","reported_name":"Venrock Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106389,"kind":"organization","name":"Venrock Partners Management V, LLC","position":5,"cik":"0001444117","reported_name":"Venrock Partners Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130200,"kind":"organization","name":"VEF Management V, LLC","position":6,"cik":"0001444112","reported_name":"VEF Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":7,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":8,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":9,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":10,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-02-18T14:13:19.000Z","date":"2022-02-17","kind":"disposition_to_issuer","acquired":false,"shares":15568571,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a \"Permitted Transferee\", as defined in the Issuer's Restated Certificate of Incorporation immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. (\"Vera Health\"), and Carbon Merger Sub, Inc. (the \"Merger Sub\"), the Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the \"Effective Time\"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a \"Permitted Transferee\", as defined in the Issuer's Restated Certificate of Incorporation immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a \"Permitted Transferee\", as defined in the Issuer's Restated Certificate of Incorporation immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Venrock Associates VI, L.P. (\"VA6\") held an aggregate of 3,707,442 shares of Class B Common Stock, Venrock Partners VI, L.P. (\"VP6\") held an aggregate of 291,092 shares of Class B Common Stock, Venrock Associates V, L.P. (\"VA5\") held an aggregate of 1,133,948 shares of Class B Common Stock and 14,047,522 shares of Class A Common Stock, Venrock Partners V, L.P. (\"VP5\") held an aggregate of 96,139 shares of Class B Common Stock and 1,190,996 shares of Class A Common Stock and Venrock Entrepreneurs Fund V, L.P. (\"VEF5\") held an aggregate of 26,643 shares of Class B Common Stock and 330,053 shares of Class A Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Venrock Management VI, LLC, Venrock Partners Management VI, LLC, Venrock Management V, LLC, VEF Management V, LLC and Venrock Partners Management V, LLC (collectively, the \"Venrock GP Entities\") are the sole general partners of VA6, VP6, VA5, VEF5 and VP5, respectively, and may be deemed to beneficially own these shares. The Venrock GP Entities expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":15568571},"source":{"system":"sec-edgar","filing":"0001209191-22-011152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000120919122011152/doc4.xml","form_type":"4"}},{"id":2385308,"issuer":{"id":130187,"kind":"organization","name":"CASTLIGHT HEALTH, INC.","symbol":"CSLT"},"owners":[{"id":130197,"kind":"organization","name":"VENROCK ASSOCIATES V LP","position":1,"cik":"0001391289","reported_name":"VENROCK ASSOCIATES V LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130198,"kind":"organization","name":"VENROCK PARTNERS V L P","position":2,"cik":"0001395760","reported_name":"VENROCK PARTNERS V L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130199,"kind":"organization","name":"Venrock Entrepreneurs Fund V, L.P.","position":3,"cik":"0001444114","reported_name":"Venrock Entrepreneurs Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106037,"kind":"organization","name":"Venrock Management V, LLC","position":4,"cik":"0001444116","reported_name":"Venrock Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106389,"kind":"organization","name":"Venrock Partners Management V, LLC","position":5,"cik":"0001444117","reported_name":"Venrock Partners Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130200,"kind":"organization","name":"VEF Management V, LLC","position":6,"cik":"0001444112","reported_name":"VEF Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":7,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":8,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":9,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":10,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2022-02-18T14:13:19.000Z","date":"2022-02-17","kind":"disposition_to_issuer","acquired":false,"shares":5255264,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. (\"Vera Health\"), and Carbon Merger Sub, Inc. (the \"Merger Sub\"), the Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the \"Effective Time\"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash at the Effective Time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Venrock Associates VI, L.P. (\"VA6\") held an aggregate of 3,707,442 shares of Class B Common Stock, Venrock Partners VI, L.P. (\"VP6\") held an aggregate of 291,092 shares of Class B Common Stock, Venrock Associates V, L.P. (\"VA5\") held an aggregate of 1,133,948 shares of Class B Common Stock and 14,047,522 shares of Class A Common Stock, Venrock Partners V, L.P. (\"VP5\") held an aggregate of 96,139 shares of Class B Common Stock and 1,190,996 shares of Class A Common Stock and Venrock Entrepreneurs Fund V, L.P. (\"VEF5\") held an aggregate of 26,643 shares of Class B Common Stock and 330,053 shares of Class A Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Venrock Management VI, LLC, Venrock Partners Management VI, LLC, Venrock Management V, LLC, VEF Management V, LLC and Venrock Partners Management V, LLC (collectively, the \"Venrock GP Entities\") are the sole general partners of VA6, VP6, VA5, VEF5 and VP5, respectively, and may be deemed to beneficially own these shares. The Venrock GP Entities expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-011152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000120919122011152/doc4.xml","form_type":"4"}},{"id":2950133,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2020-12-10T18:13:47.000Z","date":"2020-12-08","kind":"exercise","acquired":false,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, all outstanding shares of Class B Common Stock will convert automatically into Class A Common Stock upon any transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, all outstanding shares of Class B Common Stock will convert automatically into Class A Common Stock upon any transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, all outstanding shares of Class B Common Stock will convert automatically into Class A Common Stock upon any transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Consists of 5,368,880 shares of Class B Common Stock held by VA VI and 421,542 shares of Class B Common Stock held by VP VI."}],"balance_after":5790422,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001209191-20-062775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000120919120062775/doc4.xml","form_type":"4"}},{"id":2950132,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-12-10T18:13:47.000Z","date":"2020-12-10","kind":"other","acquired":false,"shares":268692,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On December 10, 2020, VM VI and VPM VI distributed an aggregate of 268,692 shares of Class A Common Stock to their members and participants."},{"field":"shares","element":"transactionShares","label":"F5","text":"On December 10, 2020, VM VI and VPM VI distributed an aggregate of 268,692 shares of Class A Common Stock to their members and participants."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On December 10, 2020, VM VI and VPM VI distributed an aggregate of 268,692 shares of Class A Common Stock to their members and participants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Consists of 1,889,497 shares of Class A Common Stock held by VA VI and 148,328 shares of Class A Common Stock held by VP VI."}],"balance_after":2037825,"source":{"system":"sec-edgar","filing":"0001209191-20-062775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000120919120062775/doc4.xml","form_type":"4"}},{"id":2950131,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-12-10T18:13:47.000Z","date":"2020-12-08","kind":"other","acquired":false,"shares":731308,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 8, 2020, VA VI and VP VI distributed an aggregate of 1,000,000 shares of Class A Common Stock to their limited partners and general partners. Of the 1,000,000 shares distributed, 249,521 shares were distributed by VA VI to its general partner, Venrock Management VI, LLC (\"VM VI\") and 19,171 shares were distributed by VP VI to its general partner, Venrock Partners Management VI, LLC (\"VPM VI\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"On December 8, 2020, VA VI and VP VI distributed an aggregate of 1,000,000 shares of Class A Common Stock to their limited partners and general partners. Of the 1,000,000 shares distributed, 249,521 shares were distributed by VA VI to its general partner, Venrock Management VI, LLC (\"VM VI\") and 19,171 shares were distributed by VP VI to its general partner, Venrock Partners Management VI, LLC (\"VPM VI\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 8, 2020, VA VI and VP VI distributed an aggregate of 1,000,000 shares of Class A Common Stock to their limited partners and general partners. Of the 1,000,000 shares distributed, 249,521 shares were distributed by VA VI to its general partner, Venrock Management VI, LLC (\"VM VI\") and 19,171 shares were distributed by VP VI to its general partner, Venrock Partners Management VI, LLC (\"VPM VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Consists of 1,889,497 shares of Class A Common Stock held by VA VI, 249,521 shares of Class A Common Stock held by VM VI, 148,328 shares of Class A Common Stock held by VP VI and 19,171 shares of Class A Common Stock held by VPM VI."}],"balance_after":2306517,"source":{"system":"sec-edgar","filing":"0001209191-20-062775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000120919120062775/doc4.xml","form_type":"4"}},{"id":2950130,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-12-10T18:13:47.000Z","date":"2020-12-08","kind":"exercise","acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Class A Common Stock received upon conversion of 3,000,000 shares of Class B Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 2,816,685 shares of Class A Common Stock held by Venrock Associates VI, L.P. (\"VA VI\") and 221,140 shares of Class A Common Stock held by Venrock Partners VI, L.P. (\"VP VI\")."}],"balance_after":3037825,"source":{"system":"sec-edgar","filing":"0001209191-20-062775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000120919120062775/doc4.xml","form_type":"4"}},{"id":3026969,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-09-18T16:32:04.000Z","date":"2020-09-18","kind":"other","acquired":false,"shares":338019,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On September 18, 2020, VM VI and VPM VI distributed an aggregate of 338,019 shares of Class A Common Stock to their members and participants pursuant to the Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"On September 18, 2020, VM VI and VPM VI distributed an aggregate of 338,019 shares of Class A Common Stock to their members and participants pursuant to the Plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Consists of 35,085 shares of Class A Common Stock held by VA VI and 2,740 shares of Class A Common Stock held by VP VI."}],"balance_after":37825,"source":{"system":"sec-edgar","filing":"0001209191-20-051155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000120919120051155/doc4.xml","form_type":"4"}},{"id":3026968,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-09-18T16:32:04.000Z","date":"2020-09-16","kind":"other","acquired":false,"shares":911981,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 16, 2020, Venrock Associates VI, L.P. (\"VA VI\") and Venrock Partners VI, L.P. (\"VP VI\") distributed an aggregate of 1,250,000 shares of Class A Common Stock to their limited partners and general partners pursuant to a Trading and Distribution Plan adopted on September 11, 2020 (the \"Plan\"). Pursuant to the terms of the Plan, of the 1,250,000 shares distributed, 313,898 shares were distributed by VA VI to its general partner, Venrock Management VI, LLC (\"VM VI\") and 24,121 shares were distributed by VP VI to its general partner, Venrock Partners Management VI, LLC (\"VPM VI\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"On September 16, 2020, Venrock Associates VI, L.P. (\"VA VI\") and Venrock Partners VI, L.P. (\"VP VI\") distributed an aggregate of 1,250,000 shares of Class A Common Stock to their limited partners and general partners pursuant to a Trading and Distribution Plan adopted on September 11, 2020 (the \"Plan\"). Pursuant to the terms of the Plan, of the 1,250,000 shares distributed, 313,898 shares were distributed by VA VI to its general partner, Venrock Management VI, LLC (\"VM VI\") and 24,121 shares were distributed by VP VI to its general partner, Venrock Partners Management VI, LLC (\"VPM VI\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consists of 35,085 shares of Class A Common Stock held by VA VI, 2,740 shares of Class A Common Stock held by VP VI, 313,898 shares of Class A Common Stock held by VM VI and 24,121 shares of Class A Common Stock held by VPM VI."}],"balance_after":375844,"source":{"system":"sec-edgar","filing":"0001209191-20-051155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000120919120051155/doc4.xml","form_type":"4"}},{"id":3137217,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2020-05-22T16:09:59.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":1013569,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents (a) 8,150,480 shares of Class B common stock held by Venrock Associates VI, L.P. (\"VA VI\") and (b) 639,942 shares of Class B common stock held by Venrock Partners VI, L.P. (\"VP VI\"). Venrock Management VI, LLC (\"VM VI\") is the sole general partner of VA VI. Venrock Partners Management VI, LLC (\"VPM VI\") is the sole general partner of VP VI. VM VI and VPM VI disclaim beneficial ownership over all shares held by VA VI and VP VI, respectively, except to the extent of their indirect pecuniary interests therein."}],"balance_after":8790422,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1013569},"source":{"system":"sec-edgar","filing":"0001495384-20-000002","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000149538420000002/edgar.xml","form_type":"4"}},{"id":3137216,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-05-22T16:09:59.000Z","date":"2020-05-20","kind":"sale","acquired":false,"shares":1013569,"price":78,"value":79058382.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents (a) 1,194,071 shares of Class A common stock held by VA VI and (b) 93,754 shares of Class A common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. VM VI and VPM VI disclaim beneficial ownership over all shares held by VA VI and VP VI, respectively, except to the extent of their indirect pecuniary interests therein."}],"balance_after":1287825,"source":{"system":"sec-edgar","filing":"0001495384-20-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000149538420000002/edgar.xml","form_type":"4"}},{"id":3137215,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-05-22T16:09:59.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":1013569,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents (a) 2,133,852 shares of Class A common stock held by VA VI and (b) 167,542 shares of Class A common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. VM VI and VPM VI disclaim beneficial ownership over all shares held by VA VI and VP VI, respectively, except to the extent of their indirect pecuniary interests therein."}],"balance_after":2301394,"source":{"system":"sec-edgar","filing":"0001495384-20-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000149538420000002/edgar.xml","form_type":"4"}},{"id":3165378,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2020-05-01T20:47:20.000Z","date":"2020-05-01","kind":"exercise","acquired":false,"shares":1287825,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents (a) 9,090,261 shares of Class B common stock held by Venrock Associates VI, L.P. (\"VA VI\") and (b) 713,730 shares of Class B common stock held by Venrock Partners VI, L.P. (\"VP VI\"). Venrock Management VI, LLC (\"VM VI\") is the sole general partner of VA VI. Venrock Partners Management VI, LLC (\"VPM VI\") is the sole general partner of VP VI. VM VI and VPM VI disclaim beneficial ownership over all shares held by VA VI and VP VI, respectively, except to the extent of their indirect pecuniary interests therein."}],"balance_after":9803991,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1287825},"source":{"system":"sec-edgar","filing":"0001495384-20-000001","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000149538420000001/edgar.xml","form_type":"4"}},{"id":3165377,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-05-01T20:47:20.000Z","date":"2020-05-01","kind":"exercise","acquired":true,"shares":1287825,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents (a) 1,194,071 shares of Class A common stock held by VA VI and (b) 93,754 shares of Class A common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. VM VI and VPM VI disclaim beneficial ownership over all shares held by VA VI and VP VI, respectively, except to the extent of their indirect pecuniary interests therein."}],"balance_after":1287825,"source":{"system":"sec-edgar","filing":"0001495384-20-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000149538420000001/edgar.xml","form_type":"4"}},{"id":3413941,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2019-09-16T17:28:56.000Z","date":"2019-09-16","kind":"exercise","acquired":true,"shares":11091816,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents (a) 7,250,375 shares of Class B common stock held by Venrock Associates VI, L.P. (\"VA VI\") and (b) 569,270 shares of Class B common stock held by Venrock Partners VI, L.P. (\"VP VI\"). Venrock Management VI, LLC (\"VM VI\"), is the sole general partner of VA VI. Venrock Partners Management VI, LLC (\"VPM VI\"), is the sole general partner of VP VI. Dr. Roberts is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents (a) 3,033,957 shares of Class B common stock held by VA VI and (b) 238,214 shares of Class B common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. Dr. Roberts is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein."}],"balance_after":11091816,"derivative":{"underlying":"Class A Common Stock","underlying_shares":11091816},"source":{"system":"sec-edgar","filing":"0001495384-19-000002","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000149538419000002/edgar.xml","form_type":"4"}},{"id":3413940,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-09-16T17:28:56.000Z","date":"2019-09-16","kind":"exercise","acquired":false,"shares":3272171,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents (a) 3,033,957 shares of Class B common stock held by VA VI and (b) 238,214 shares of Class B common stock held by VP VI. VM VI is the sole general partner of VA VI. VPM VI is the sole general partner of VP VI. Dr. Roberts is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":3272171},"source":{"system":"sec-edgar","filing":"0001495384-19-000002","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000149538419000002/edgar.xml","form_type":"4"}},{"id":3413939,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":1,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":2,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":3,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":4,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Preferred Stock","published_at":"2019-09-16T17:28:56.000Z","date":"2019-09-16","kind":"exercise","acquired":false,"shares":7819645,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering and had no expiration date.  Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents (a) 7,250,375 shares of Class B common stock held by Venrock Associates VI, L.P. (\"VA VI\") and (b) 569,270 shares of Class B common stock held by Venrock Partners VI, L.P. (\"VP VI\"). Venrock Management VI, LLC (\"VM VI\"), is the sole general partner of VA VI. Venrock Partners Management VI, LLC (\"VPM VI\"), is the sole general partner of VP VI. Dr. Roberts is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his indirect pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class B Common Stock","underlying_shares":7819645},"source":{"system":"sec-edgar","filing":"0001495384-19-000002","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000149538419000002/edgar.xml","form_type":"4"}},{"id":3497260,"issuer":{"id":130187,"kind":"organization","name":"CASTLIGHT HEALTH, INC.","symbol":"CSLT"},"owners":[{"id":130197,"kind":"organization","name":"VENROCK ASSOCIATES V LP","position":1,"cik":"0001391289","reported_name":"VENROCK ASSOCIATES V LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130198,"kind":"organization","name":"VENROCK PARTNERS V L P","position":2,"cik":"0001395760","reported_name":"VENROCK PARTNERS V L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130199,"kind":"organization","name":"Venrock Entrepreneurs Fund V, L.P.","position":3,"cik":"0001444114","reported_name":"Venrock Entrepreneurs Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106037,"kind":"organization","name":"Venrock Management V, LLC","position":4,"cik":"0001444116","reported_name":"Venrock Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106389,"kind":"organization","name":"Venrock Partners Management V, LLC","position":5,"cik":"0001444117","reported_name":"Venrock Partners Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130200,"kind":"organization","name":"VEF Management V, LLC","position":6,"cik":"0001444112","reported_name":"VEF Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":7,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":8,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":9,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":10,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2019-06-07T17:09:09.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":3998534,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 6,026,800 shares of Series B Preferred Stock of Jiff, Inc. (\"Jiff\") held by Venrock Associates VI, L.P. (\"VA6\"), 473,200 shares of Jiff's Series B Preferred Stock held by Venrock Partners VI, L.P. (\"VP6\"), 1,428,732 shares of Jiff's Series C Preferred Stock held by VA6, and 112,178 shares of Jiff's Series C Preferred Stock held by VP6 pursuant to the Agreement and Plan of Merger and Reorganization dated as of January 4, 2017 (the \"Merger Agreement\") by and among the Issuer, Neptune Acquisition Subsidiary, Inc., a Delaware corporation and wholly owned subsidiary of Issuer (\"Merger Sub\"), Jiff and Fortis Advisors LLC, as the Stockholders' Agent (\"Stockholders' Agent\"). Pursuant to the Merger Agreement, on April 3, 2017 (the \"Effective Time\"), Merger Sub merged with and into Jiff with Jiff surviving the merger as a wholly owned subsidiary of Issuer (the \"Merger\"). At the Effective Time, the closing price of the Issuer's Class B Common Stock was $3.65 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Of the 3,998,534 shares issued as reported herein, 401,779 shares and 31,546 shares held by VA6 and VP6, respectively, are currently being held in escrow for 12-months following the Merger to serve as partial security for certain indemnification obligations of Jiff stockholders pursuant to the Merger Agreement and 7,441 shares and 584 shares held by VA6 and VP6, respectively, are being held in an expense fund, which will be used for the purposes of paying directly or reimbursing the Stockholders' Agent for out-of-pocket costs and expenses and legal fees incurred by the Stockholders' Agent in connection with the administration of its duties."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Merger Agreement provides that the former equityholders of Jiff (other than the holders of Jiff's Series A Preferred Stock) will receive additional shares of the Issuer's Class B Common Stock upon the achievement by the Jiff business of certain milestones in FY2017. Such former equityholders of Jiff will receive additional shares of the Issuer's Class B Common Stock if the Jiff business achieves at least $25 million in revenue in FY2017 and if the Jiff business achieves at least $25 million in net new bookings during FY2017, and such right to receive additional shares subject to this earn-out right became fixed and irrevocable at the Effective Time. For more information on the earnout, please refer to the Merger Agreement filed as Exhibit 2.1 to the Issuer's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on January 4, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"VA6 holds an aggregate of 3,707,442 shares, VP6 holds an aggregate of 291,092 shares, Venrock Associates V, L.P. (\"VA5\") holds an aggregate of 1,133,948 shares, Venrock Partners V, L.P. (\"VP5\") holds an aggregate of 96,139 shares and Venrock Entrepreneurs Fund V, L.P. (\"VEF5\") holds an aggregate of 26,643 shares. Venrock Management VI, LLC, Venrock Partners Management VI, LLC, Venrock Management V, LLC, VEF Management V, LLC and Venrock Partners Management V, LLC (collectively, the \"Venrock GP Entities\") are the sole general partners of VA6, VP6, VA5, VEF5 and VP5 (collectively, the \"Funds\"), respectively, and may be deemed to beneficially own these shares. The Venrock GP Entities expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein."}],"balance_after":5255264,"source":{"system":"sec-edgar","filing":"0001391289-19-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000139128919000001/edgar.xml","form_type":"4/A","original_submission_date":"2017-04-05"}},{"id":4358291,"issuer":{"id":130187,"kind":"organization","name":"CASTLIGHT HEALTH, INC.","symbol":"CSLT"},"owners":[{"id":130197,"kind":"organization","name":"VENROCK ASSOCIATES V LP","position":1,"cik":"0001391289","reported_name":"VENROCK ASSOCIATES V LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130198,"kind":"organization","name":"VENROCK PARTNERS V L P","position":2,"cik":"0001395760","reported_name":"VENROCK PARTNERS V L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130199,"kind":"organization","name":"Venrock Entrepreneurs Fund V, L.P.","position":3,"cik":"0001444114","reported_name":"Venrock Entrepreneurs Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106037,"kind":"organization","name":"Venrock Management V, LLC","position":4,"cik":"0001444116","reported_name":"Venrock Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106389,"kind":"organization","name":"Venrock Partners Management V, LLC","position":5,"cik":"0001444117","reported_name":"Venrock Partners Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130200,"kind":"organization","name":"VEF Management V, LLC","position":6,"cik":"0001444112","reported_name":"VEF Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130201,"kind":"organization","name":"Venrock Associates VI, L.P.","position":7,"cik":"0001495384","reported_name":"Venrock Associates VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130202,"kind":"organization","name":"Venrock Partners VI, L.P.","position":8,"cik":"0001495386","reported_name":"Venrock Partners VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105876,"kind":"organization","name":"Venrock Management VI, LLC","position":9,"cik":"0001495383","reported_name":"Venrock Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130203,"kind":"organization","name":"Venrock Partners Management VI, LLC","position":10,"cik":"0001495385","reported_name":"Venrock Partners Management VI, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2017-04-05T19:07:21.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":3965979,"ownership":{"direct":false,"nature":"By Funds"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 6,026,800 shares of Series B Preferred Stock of Jiff, Inc. (\"Jiff\") held by Venrock Associates VI, L.P. (\"VA6\"), 473,200 shares of Jiff's Series B Preferred Stock held by Venrock Partners VI, L.P. (\"VP6\"), 1,428,732 shares of Jiff's Series C Preferred Stock held by VA6, and 112,178 shares of Jiff's Series C Preferred Stock held by VP6 pursuant to the Agreement and Plan of Merger and Reorganization dated as of January 4, 2017 (the \"Merger Agreement\") by and among the Issuer, Neptune Acquisition Subsidiary, Inc., a Delaware corporation and wholly owned subsidiary of Issuer (\"Merger Sub\"), Jiff and Fortis Advisors LLC, as the Stockholders' Agent (\"Stockholders' Agent\"). Pursuant to the Merger Agreement, on April 3, 2017 (the \"Effective Time\"), Merger Sub merged with and into Jiff with Jiff surviving the merger as a wholly owned subsidiary of Issuer (the \"Merger\"). At the Effective Time, the closing price of the Issuer's Class B Common Stock was $3.65 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Of the 3,965,979 shares issued as reported herein, 401,779 shares and 31,546 shares held by VA6 and VP6, respectively, are currently being held in escrow for 12-months following the Merger to serve as partial security for certain indemnification obligations of Jiff stockholders pursuant to the Merger Agreement and 7,441 shares and 584 shares held by VA6 and VP6, respectively, are being held in an expense fund, which will be used for the purposes of paying directly or reimbursing the Stockholders' Agent for out-of-pocket costs and expenses and legal fees incurred by the Stockholders' Agent in connection with the administration of its duties."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Merger Agreement provides that the former equityholders of Jiff (other than the holders of Jiff's Series A Preferred Stock) will receive additional shares of the Issuer's Class B Common Stock upon the achievement by the Jiff business of certain milestones in FY2017. Such former equityholders of Jiff will receive additional shares of the Issuer's Class B Common Stock if the Jiff business achieves at least $25 million in revenue in FY2017 and if the Jiff business achieves at least $25 million in net new bookings during FY2017, and such right to receive additional shares subject to this earn-out right became fixed and irrevocable at the Effective Time. For more information on the earnout, please refer to the Merger Agreement filed as Exhibit 2.1 to the Issuer's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on January 4, 2017."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"VA6 holds an aggregate of 3,677,257 shares, VP6 holds an aggregate of 288,722 shares, Venrock Associates V, L.P. (\"VA5\") holds an aggregate of 1,133,948 shares, Venrock Partners V, L.P. (\"VP5\") holds an aggregate of 96,139 shares and Venrock Entrepreneurs Fund V, L.P. (\"VEF5\") holds an aggregate of 26,643 shares. Venrock Management VI, LLC, Venrock Partners Management VI, LLC, Venrock Management V, LLC, VEF Management V, LLC and Venrock Partners Management V, LLC (collectively, the \"Venrock GP Entities\") are the sole general partners of VA6, VP6, VA5, VEF5 and VP5 (collectively, the \"Funds\"), respectively, and may be deemed to beneficially own these shares. The Venrock GP Entities expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein."}],"balance_after":5222709,"source":{"system":"sec-edgar","filing":"0001391289-17-000001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1495385/000139128917000001/edgar.xml","form_type":"4"}}]}